Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cellid Co., Ltd.

Clinical trials sponsored by Cellid Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Vaccine trains immune system to fight HPV-Positive head and neck tumors Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Vaccine trains immune system to fight HPV-Positive head and neck tumors

Disease control Recruiting now

This trial tests a vaccine called BVAC-E6E7 in people with head and neck cancer linked to HPV types 16 or 18 that cannot be removed by surgery or has spread. The vaccine is designed to teach the immune system to attack cancer cells. The study first checks safety and the best dose…

Phase 1/2 • Sponsor: Cellid Co., Ltd. • Aim: Disease control

Last updated Jul 10, 2026 00:00 UTC